Addressing Industry Challenges In mRNA Product Commercialization

Source: Thermo Fisher Scientific
mRNA GettyImages-1356994723

The rapid development and approval of mRNA-based vaccines during the COVID-19 pandemic has spurred a renewed interest in mRNA technology, with scientists exploring new application areas such as oncology, HIV, rare diseases, and even personalized medicine. While the speed of production and flexibility of mRNA are appealing, several industry challenges must still be addressed to realize the full potential and further expand its use.

View this educational webinar regarding key challenge areas for mRNA-based product developers and the innovative strategies being used to address them.

Learning Objectives Include:

  • Process optimization opportunities for in vitro transcription, purification, and encapsulation
  • Novel mRNA delivery systems and other innovations
  • Strategies to improve storage and supply chain logistics
  • Navigating an uncertain regulatory environment
  • Overview of Thermo Fisher Scientific’s experience, capacity, and integrated mRNA development and manufacturing services
access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene